Ekos Wins $2.7M NIH Grant

Luke Timmerman6/7/10

Ekos, the Bothell, WA-based company that uses ultrasound to treat vascular diseases, said today it has received a $2.7 million grant from the National Institutes of Health to study its method of treating hemorrhagic strokes. About 100,000 patients in the U.S. have this condition, in which a blood vessel ruptures in the brain and creates dangerous swelling and clots. Ekos, with the help of neurosurgeon David Newell at Swedish Medical Center, has worked to deliver its tiny ultrasound probe into the brain where it is supposed to help loosen up the clot and make clot-dissolving drugs more effective.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.